首页> 外文期刊>Journal of Pharmacological and Toxicological Methods >The use of small interfering RNA to elucidate the activity and function of ion channel genes in an intact tissue.
【24h】

The use of small interfering RNA to elucidate the activity and function of ion channel genes in an intact tissue.

机译:使用小分子干扰RNA阐明完整组织中离子通道基因的活性和功能。

获取原文
获取原文并翻译 | 示例
           

摘要

Small interfering RNA (siRNA) directs the targeted destruction of mRNA encoding a specific protein, in a process known as RNA interference (RNAi). This stops translation of the targeted mRNA into protein, effectively silencing the gene. RNAi is a recent discovery, identified in mammalian cells in 2001, but it has rapidly advanced into a practical technique and is being used increasingly to investigate mammalian gene function. Tools are available to induce RNAi in cell lines, intact tissue preparations and even in vivo. Depending on the method used, loss of gene expression may be transient or sustained, enabling a wide range of functions to be investigated. RNAi therefore offers a powerful technique that can be used to produce targeted knockout of ion channel genes in mammalian cells. Its applications potentially include identification of ion channel function in health and disease, identification of novel channel genes and drug target validation. This paper outlines our current understanding of siRNA and the experimental requirements for producing efficient RNAi and gene silencing. Effective RNAi requires an appropriate siRNA sequence to be designed and an efficient method for delivering the siRNA to the cells of interest. Since not all potential siRNA sequences are effective, it is also important to verify the loss of gene expression by measuring the level of channel protein remaining. Limitations of the methods available for delivering siRNA are one of the main obstacles to producing efficient RNAi, especially in intact tissue preparations. Here we describe an in vitro method for targeted RNAi against the TASK-1 potassium channel gene in an isolated vascular preparation, using a DNA construct to direct the expression of siRNA, along with a non-viral method for transfecting cells within the vessel. Successful silencing of the TASK-1 gene is verified by immunostaining with an antibody directed against the TASK-1 protein.
机译:小干扰RNA(siRNA)在称为RNA干扰(RNAi)的过程中指导靶向破坏编码特定蛋白质的mRNA。这会停止将目标mRNA转换为蛋白质,从而有效沉默基因。 RNAi是最近发现的,在2001年在哺乳动物细胞中被发现,但是它已迅速发展成为一种实用技术,并且正越来越多地用于研究哺乳动物基因的功能。有工具可以在细胞系,完整的组织制剂乃至体内诱导RNAi。根据所用方法的不同,基因表达的丧失可能是暂时的或持续的,从而使人们需要研究各种各样的功能。因此,RNAi提供了一种强大的技术,可用于在哺乳动物细胞中产生靶向性的离子通道基因敲除。它的应用潜在包括在健康和疾病中离子通道功能的鉴定,新型通道基因的鉴定和药物靶标的验证。本文概述了我们目前对siRNA的理解以及产生有效RNAi和基因沉默的实验要求。有效的RNAi需要设计适当的siRNA序列,以及将siRNA传递至目标细胞的有效方法。由于并非所有潜在的siRNA序列都有效,因此通过测量剩余通道蛋白的水平来验证基因表达的损失也很重要。可用于递送siRNA的方法的局限性是产生有效RNAi的主要障碍之一,特别是在完整​​的组织制剂中。在这里,我们描述了一种体外方法,用于针对孤立的血管制剂中针对TASK-1钾通道基因的靶向RNAi,使用DNA构建体指导siRNA的表达,以及用于转染血管内细胞的非病毒方法。通过用针对TASK-1蛋白的抗体进行免疫染色,可以验证TASK-1基因是否成功沉默。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号